GATA3 antibody

Catalog No. ABIN967621

This Mouse Monoclonal antibody specifically detects GATA3 in WB, IHC (f) and BI. It exhibits reactivity toward Human, Mouse and Rat and has been mentioned in 7+ publications.

Quick Overview for GATA3 antibody (ABIN967621)

Target: GATA3 (GATA Binding Protein 3 (GATA3))

Reactivity: Human, Mouse, Rat

Host: Mouse

Clonality: Monoclonal

Conjugate: This GATA3 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f)), BioImaging (BI)

Clone: L50-823

Product Details anti-GATA3 Antibody

Brand: BD Pharmingen™

Cross-Reactivity (Details): Predicted: Rat

Characteristics: 1. Please refer to us for technical protocols.
2. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
4. This antibody has been developed and certified for the bioimaging application. However, a routine bioimaging test is not performed on every lot. Researchers are encouraged to titrate the reagent for optimal performance.

Purification: The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Immunogen: Conserved peptide between the trans-activation and DNA-binding domains of human, mouse and rat GATA3

Isotype: IgG1 kappa

Application Details

Application Notes: Methanol Procedure for a 96-well plate, with nuclear counterstain:
1. Seed the cells in appropriate culture medium at ~10,000 cells per well in an 96-well Imaging Plate , and culture overnight.
2. Remove the culture medium from the wells, and fix the cells by adding 100 µl of fresh 3.7% Formaldehyde in PBS or fixation buffer to each well and incubating for 10 minutes at room temperature (RT).
3. Remove the fixative from the wells, and permeabilize the cells by adding 100 µl of -20°C 90% methanol to each well and incubating for 5 minutes at RT.
4. Remove the permeabilizer, and wash the wells twice with 100 myl of 1× PBS.
5. Remove the PBS, and block the cells by adding 100 µl of blocking buffer (3% FBS in 1× PBS) or to each well and incubating for 30 minutes at RT.
6. Remove the blocking buffer, dilute the antibody in blocking buffer or Stain Buffer (FBS), and stain the cells by adding 50 µl of the diluted antibody to each well and incubating for 1 hour at RT.
7. Remove the diluted antibody, and wash the wells three times with 100 myl of 1× PBS.
8. Remove the PBS, dilute the second-step reagent in blocking buffer or Stain Buffer (FBS), and stain the cells by adding 50 µl of the diluted second-step reagent to each well and incubating for 1 hour at RT.
9. Remove the diluted second-step reagent, and wash the wells three times with 100 myl of 1× PBS.
10. Remove the PBS, and counter-stain the nuclei by adding 100 ml of a 2 mg/ml solution of Hoechst 33342 in 1× PBS to each well at least 15 minutes before imaging.
11. View and analyze the cells on an appropriate imaging instrument.

Comment:

Related Products: ABIN967389

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Aqueous buffered solution containing ≤0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store undiluted at 4°C.

References for anti-GATA3 antibody (ABIN967621)

Kouros-Mehr, Slorach, Sternlicht, Werb: "GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland." in: Cell, Vol. 127, Issue 5, pp. 1041-55, (2006) (PubMed).

Usary, Llaca, Karaca, Presswala, Karaca, He, Langerød, Kåresen, Oh, Dressler, Lønning, Strausberg, Chanock, Børresen-Dale, Perou: "Mutation of GATA3 in human breast tumors." in: Oncogene, Vol. 23, Issue 46, pp. 7669-78, (2004) (PubMed).

Steenbergen, OudeEngberink, Kramer, Schrijnemakers, Verheijen, Meijer, Snijders: "Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis." in: The American journal of pathology, Vol. 160, Issue 6, pp. 1945-51, (2002) (PubMed).

Van Esch, Groenen, Nesbit, Schuffenhauer, Lichtner, Vanderlinden, Harding, Beetz, Bilous, Holdaway, Shaw, Fryns, Van de Ven, Thakker, Devriendt: "GATA3 haplo-insufficiency causes human HDR syndrome." in: Nature, Vol. 406, Issue 6794, pp. 419-22, (2000) (PubMed).

Zheng, Flavell: "The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells." in: Cell, Vol. 89, Issue 4, pp. 587-96, (1997) (PubMed).

Yang, Gu, Romeo, Bories, Motohashi, Yamamoto, Engel: "Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains." in: Molecular and cellular biology, Vol. 14, Issue 3, pp. 2201-12, (1994) (PubMed).

Marine, Winoto: "The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, Issue 16, pp. 7284-8, (1991) (PubMed).

Target Details for GATA3

Target: GATA3 (GATA Binding Protein 3 (GATA3))

Alternative Name: GATA3

Background: GATA3 (GATA binding protein 3) is a member of the GATA family of transcription factors. This ~50-kDa nuclear protein regulates the development and subsequent maintenance of multiple tissues. GATA3 is involved in the development of T lymphocytes (regulates T cell receptor subunit gene expression) and the differentiation of mature T cells to become Th2 cells. The expressed levels of normal or mutant GATA3 are also associated with the behaviors of various cancer cells including estrogen receptor-positive breast carcinoma cells.
The L50-823 monoclonal antibody recognizes human and mouse GATA3.

Molecular Weight: 50 kDa

Pathways: Hormone Transport, Regulation of Hormone Metabolic Process, Tube Formation